SEC Filing Summary

Jacqualyn A. Fouse, a director at Agios Pharmaceuticals, Inc. (AGIO), reported several transactions on June 18, 2026. She acquired 2,816 shares of common stock, increasing her total holdings to 154,156 shares. Additionally, Fouse was granted 2,927 restricted stock units (RSUs) that vest on June 18, 2027, and 14,950 stock options with an exercise price of $34.16, vesting on June 18, 2027. She also disposed of 2,816 RSUs that vested on June 18, 2026. All transactions were reported as direct ownership.